X-linked Spinocerebellar Ataxia Type 3
Neurology·MeSH: Episodic Ataxia, Type 5
Prevalence
0.1 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target X-linked Spinocerebellar Ataxia Type 3?
There are 1 clinical trial targeting X-linked Spinocerebellar Ataxia Type 3 tracked by BioSniper.
What is the prevalence of X-linked Spinocerebellar Ataxia Type 3?
The estimated prevalence of X-linked Spinocerebellar Ataxia Type 3 is approximately 0.1 per 100,000 population.
Deep-dive into X-linked Spinocerebellar Ataxia Type 3
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis